RA CAPITAL MANAGEMENT, L.P. Diversified Active

CIK: 0001346824 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value ($000): $753,991 (100.0% shares, 0.0% debt)

Holdings (29)

ACAD ACADIA PHARMACEUTICALS INC 15.7%
Value ($000) $118,516 Shares 6,529,810 Est. Cost $13.77 Unrealized 0.0%
ACAD ACADIA PHARMACEUTICALS INC 12.0%
Value ($000) $90,750 Shares 5,000,000 Est. Cost $13.77 Unrealized 0.0%
ACHILLION PHARMACEUTICALS IN 8.1%
Value ($000) $60,984 Shares 7,455,202 Est. Cost $8.18 Unrealized
KERYX BIOPHARMACEUTICALS INC 5.6%
Value ($000) $42,275 Shares 5,659,285 Est. Cost $7.47 Unrealized
SGMO SANGAMO BIOSCIENCES INC 5.6%
Value ($000) $41,925 Shares 5,368,094 Est. Cost $8.72 Unrealized 0.0%
DYAX CORP 5.0%
Value ($000) $37,743 Shares 10,908,379 Est. Cost $3.46 Unrealized
NEWLINK GENETICS CORP 4.8%
Value ($000) $36,291 Shares 1,840,294 Est. Cost $19.72 Unrealized
NOVAVAX INC 4.7%
Value ($000) $35,200 Shares 17,170,801 Est. Cost $2.05 Unrealized
THERAPEUTICSMD INC 4.5%
Value ($000) $34,126 Shares 11,262,608 Est. Cost $3.03 Unrealized
INSM INSMED INC 3.9%
Value ($000) $29,102 Shares 2,433,319 Est. Cost $10.22 Unrealized 0.0%
DERMA SCIENCES INC 3.5%
Value ($000) $26,632 Shares 1,994,876 Est. Cost $13.35 Unrealized
SUNESIS PHARMACEUTICALS INC 3.2%
Value ($000) $24,454 Shares 4,716,296 Est. Cost $5.19 Unrealized
XOMA CORP DEL 3.2%
Value ($000) $24,316 Shares 6,698,558 Est. Cost $3.63 Unrealized
SGMO SANGAMO BIOSCIENCES INC 3.1%
Value ($000) $23,430 Shares 3,000,000 Est. Cost $8.72 Unrealized 0.0%
HYPERION THERAPEUTICS INC 2.6%
Value ($000) $19,863 Shares 902,858 Est. Cost $22.00 Unrealized
RECEPTOS INC 2.6%
Value ($000) $19,393 Shares 975,000 Est. Cost $19.89 Unrealized
ACHILLION PHARMACEUTICALS IN 2.2%
Value ($000) $16,360 Shares 2,000,000 Est. Cost $8.18 Unrealized
OMER OMEROS CORP 2.0%
Value ($000) $14,883 Shares 2,953,004 Est. Cost $4.61 Unrealized 0.0%
ONCOGENEX PHARMACEUTICALS IN 1.1%
Value ($000) $8,461 Shares 863,332 Est. Cost $9.80 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 1.0%
Value ($000) $7,724 Shares 436,145 Est. Cost $19.50 Unrealized 0.0%
KERYX BIOPHARMACEUTICALS INC 1.0%
Value ($000) $7,470 Shares 1,000,000 Est. Cost $7.47 Unrealized
ENZO BIOCHEM INC 0.9%
Value ($000) $6,964 Shares 3,348,029 Est. Cost $2.08 Unrealized
DYNAVAX TECHNOLOGIES CORP 0.9%
Value ($000) $6,600 Shares 6,000,000 Est. Cost $1.10 Unrealized
PRTA PROTHENA CORP PLC 0.9%
Value ($000) $6,427 Shares 497,807 Est. Cost $9.30 Unrealized 0.0%
ARROWHEAD RESH CORP 0.8%
Value ($000) $6,230 Shares 3,114,755 Est. Cost $2.00 Unrealized
EPIZYME INC 0.6%
Value ($000) $4,248 Shares 151,000 Est. Cost $28.13 Unrealized
SENOMYX INC 0.3%
Value ($000) $2,127 Shares 975,610 Est. Cost $2.18 Unrealized
TRANZYME INC 0.2%
Value ($000) $1,269 Shares 2,700,000 Est. Cost $0.47 Unrealized
SAVIENT PHARMACEUTICALS INC 0.0%
Value ($000) $228 Shares 1,000,000 Est. Cost $0.23 Unrealized